Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-12

Clinical Trial Update: Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)

View source ↗

Summary

A post-marketing surveillance study of infliximab (Remicade) in chronic inflammatory diseases has completed, with results posted in 2012. The study gathered saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid, Spondylitis, Ankylosing | Status: COMPLETED | Results posted: 2012-09-12